Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor
Clinical trial NCT02426086 · COMPLETED
Trial details
- NCT number
- NCT02426086
- Sponsor
- Geron Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-28
- Primary completion
- 2018-04-26
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.